-
Mashup Score: 4
Back to home page
Categories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 0Place of care manufacturing of chimeric antigen receptor cells: opportunities and challenges - 1 year(s) ago
The landscape of therapeutic options for B cell malignancies has fundamentally changed with regulatory and marketing approval of chimeric antigen rece…
Source: www.sciencedirect.comCategories: Hematologists1, Latest HeadlinesTweet-
Place of care manufacturing of chimeric antigen receptor cells: opport... https://t.co/O8KdsfbvAl
-
-
Mashup Score: 0Gene therapy can make a real impact on global health but we need equitable access, say experts - 1 year(s) ago
Five clinical experts across low- and middle-income countries explain what steps need to be taken to realize the potential of gene therapy around the world.
Source: World Economic ForumCategories: Hematologists1, Latest HeadlinesTweet-
Gene therapy can make a real impact on global health but we need equitable access, say experts https://t.co/aCEc7FbjgR via @wef
-
-
Mashup Score: 4
Chimeric Antigen Receptor (CAR) T cell therapy is an accepted standard of care for relapsed/refractory B cell malignancies. However, the high cost of existing industry-driven centralized production makes this therapy unaffordable in low and middle-income countries. Decentralized or point of care manufacturing has the potential to overcome some of these challenges. Here we demonstrate a…
Source: NatureCategories: Hematologists1, Latest HeadlinesTweet-
RT @DrArunCMC: VELCART 😊 - @hamenth_k @udaypkulkarni @MathewsVikram . https://t.co/WjQ1xQMtDE https://t.co/wiWpHtLOMx
-
-
Mashup Score: 1Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward - 2 year(s) ago
The selection of cancer medicines for national procurement requires deliberate evaluation of population benefit, budget impact, sustainability, and health system capacity. However, this process is complicated by numerous challenges, including the large volume and rapid pace of newly developed therapies offering marginal gains at prohibitively high prices. The WHO Model List of Essential Medicines…
Source: The Lancet Global HealthCategories: Hematologists1, Latest HeadlinesTweet-
Cancer and essential medicines. A lot to learn Congratulations Manju Sengar - Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward https://t.co/LHP30FssU6
-
-
Mashup Score: 4PG CME Haematology - 2 year(s) ago
Event Sponsors
Source: www.pgcmehematology.netCategories: Hematologists1, Latest HeadlinesTweet-
https://t.co/sVHulMLldr Registration is still open https://t.co/bo3VMgkzne
-
-
Mashup Score: 1Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach - 2 year(s) ago
Click on the article title to read more.
Source: Wiley Online LibraryCategories: Hematologists1, Latest HeadlinesTweet-
Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach https://t.co/NCDwJsTy6h @HCC_HemeCancer
-
-
Mashup Score: 0Last song of lata mangeshkar - 2 year(s) agoSource: YouTubeCategories: Hematologists1, Latest HeadlinesTweet
-
Last song of lata mangeshkar https://t.co/pGZ97LvU9p via @YouTube Thank you and RIP.
-
-
Mashup Score: 2Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia | Blood Advances | American Society of Hematology - 2 year(s) ago
Key Points. Metabolic rewiring promotes ATO resistance in APL, independent of PML mutation status.Inhibition of mitochondrial respiration combined with ATO is a
Source: ashpublications.orgCategories: Hematologists1, Latest HeadlinesTweet-
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia | Blood Advances | American Society of Hematology https://t.co/F7ORXeYAR3
-
-
Mashup Score: 0
Key Points. 14% of newly diagnosed APL patients in the Vizient Clinical Data Base died during initial admission or were discharged to hospice.Adverse outcomes w
Source: ashpublications.orgCategories: Hematologists1, Latest HeadlinesTweet-
Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States | Blood Advances | American Society of Hematology https://t.co/mTkPGJJdNr
-
RT @OffCMCVellore: .#AI #symposium @OffCMCVellore this Friday, Saturday (17, 18 Mar.) Register now: https://t.co/vFrTIoVTve Inperson only e…